Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 2Interventional 1

Sponsor

Cancer Type

Myeloid 1

Conditions

Breast Neoplasms 58Neoplasms 52Lung Neoplasms 33Colorectal Neoplasms 28Carcinoma, Non-Small-Cell Lung 25Prostatic Neoplasms 22Melanoma 19Pancreatic Neoplasms 17Ovarian Neoplasms 16Uterine Cervical Neoplasms 14Sarcoma 12Multiple Myeloma 12Lymphoma 11Glioma 11Glioblastoma 11Neoplasm Metastasis 10Leukemia, Myeloid, Acute 10Colonic Neoplasms 10Neoplastic Cells, Circulating 9Hematologic Neoplasms 9Lymphoma, Follicular 8Head and Neck Neoplasms 8Leukemia 7Carcinoma, Hepatocellular 7Brain Neoplasms 7Squamous Cell Carcinoma of Head and Neck 6Papillomavirus Infections 6Myelodysplastic Syndromes 6Endometrial Neoplasms 6Disease 6

Interventions

fludarabine phosphate 29Peripheral Blood Stem Cell Transplantation 26Cyclophosphamide 25ruxolitinib 22Busulfan 21Tacrolimus 16Whole-Body Irradiation 15Mycophenolic Acid 14Methotrexate 13Cyclosporine 12Antilymphocyte Serum 11Hydroxyurea 10Aspirin 9fludarabine 8Filgrastim 8Melphalan 7Etoposide 7Decitabine 7peginterferon alfa-2a 6Imatinib Mesylate 6Cytarabine 611-(2-pyrrolidin-1-ylethoxy)-14,19-dioxa-5,7,26-triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene 6givinostat hydrochloride 5givinostat 5Radiotherapy 5Prednisone 5Carboplatin 5Biopsy 5Topotecan 4Thiotepa 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Polycythemia Vera × Blood Specimen Collection × Clear all
NCT03003325 2024-09-19

Low-PV

FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS

Phase 2 Completed
127 enrolled
Myeloid

Polycythemia Vera

Data powered by HemOnc (CC BY 4.0) Colophon âš¡